Godshalk Welsh Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$419K Hold
1,570
0.24% 97
2025
Q4
$394K Hold
1,570
0.22% 93
2025
Q3
$451K Hold
1,570
0.26% 91
2025
Q2
$412K Buy
1,570
+35
+2% +$8.52K 0.25% 97
2025
Q1
$357K Sell
1,535
-60
-4% -$14.6K 0.23% 95
2024
Q4
$366K Hold
1,595
0.24% 95
2024
Q3
$356K Buy
1,595
+15
+0.9% +$3.3K 0.23% 96
2024
Q2
$322K Hold
1,580
0.21% 96
2024
Q1
$345K Buy
1,580
+25
+2% +$5.51K 0.23% 94
2023
Q4
$353K Buy
1,555
+140
+10% +$29.4K 0.25% 92
2023
Q3
$284K Buy
1,415
+59
+4% +$12.4K 0.21% 97
2023
Q2
$281K Hold
1,356
0.19% 102
2023
Q1
$267K Buy
1,356
+58
+4% +$11.9K 0.19% 103
2022
Q4
$263K Buy
+1,298
New +$254K 0.19% 100
2015
Q1
Sell
-116
Closed -$11K 195
2014
Q4
$11K Buy
+116
New +$10.2K 0.01% 260

Other funds holding LH

Godshalk Welsh Capital Management's LH Position: Q1 2026 in Review

Godshalk Welsh Capital Management held its Labcorp (LH) position steady in Q1 2026 at 1,570 shares worth $419K. The position accounts for 0.24% of the portfolio, ranked #97.

Godshalk Welsh Capital Management first reported a position in LH in Q4 2014 and has held it in 15 quarters since. The position peaked at $451K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Godshalk Welsh Capital Management held 1,570 shares of Labcorp worth $419K as of Q1 2026.
  • Godshalk Welsh Capital Management left its Labcorp share count unchanged in Q1 2026.
  • Labcorp made up 0.24% of Godshalk Welsh Capital Management's portfolio in Q1 2026, its #97 holding.
  • Godshalk Welsh Capital Management first reported a position in Labcorp in Q4 2014 and has held it in 15 quarters since.
  • Godshalk Welsh Capital Management's Labcorp position peaked at $451K in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Godshalk Welsh Capital Management's 13F filing for Q1 2026, filed 13 May 2026.